nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—UGT1A9—Irinotecan—pancreatic cancer	0.199	0.326	CbGbCtD
Tapentadol—UGT2B7—Epirubicin—pancreatic cancer	0.194	0.317	CbGbCtD
Tapentadol—CYP2C19—Tamoxifen—pancreatic cancer	0.0521	0.0854	CbGbCtD
Tapentadol—CYP2C9—Tamoxifen—pancreatic cancer	0.0433	0.071	CbGbCtD
Tapentadol—CYP2D6—Tamoxifen—pancreatic cancer	0.0396	0.0649	CbGbCtD
Tapentadol—CYP2D6—Erlotinib—pancreatic cancer	0.0337	0.0552	CbGbCtD
Tapentadol—CYP2C9—Fluorouracil—pancreatic cancer	0.0319	0.0523	CbGbCtD
Tapentadol—HTR3A—enteric nervous system—pancreatic cancer	0.0232	0.686	CbGeAlD
Tapentadol—CYP2D6—Doxorubicin—pancreatic cancer	0.0166	0.0272	CbGbCtD
Tapentadol—UGT1A9—digestive system—pancreatic cancer	0.00227	0.0669	CbGeAlD
Tapentadol—HTR3A—islet of Langerhans—pancreatic cancer	0.00222	0.0656	CbGeAlD
Tapentadol—UGT2B7—digestive system—pancreatic cancer	0.00183	0.0539	CbGeAlD
Tapentadol—HTR3A—digestive system—pancreatic cancer	0.00133	0.0394	CbGeAlD
Tapentadol—SLC6A4—digestive system—pancreatic cancer	0.00102	0.03	CbGeAlD
Tapentadol—CYP2C19—digestive system—pancreatic cancer	0.000843	0.0249	CbGeAlD
Tapentadol—CYP2C9—digestive system—pancreatic cancer	0.000654	0.0193	CbGeAlD
Tapentadol—CYP2D6—digestive system—pancreatic cancer	0.00049	0.0145	CbGeAlD
Tapentadol—Dermatitis—Erlotinib—pancreatic cancer	0.000387	0.00169	CcSEcCtD
Tapentadol—Angiopathy—Docetaxel—pancreatic cancer	0.000387	0.00169	CcSEcCtD
Tapentadol—Insomnia—Gemcitabine—pancreatic cancer	0.000386	0.00168	CcSEcCtD
Tapentadol—Dyspepsia—Irinotecan—pancreatic cancer	0.000386	0.00168	CcSEcCtD
Tapentadol—Immune system disorder—Docetaxel—pancreatic cancer	0.000385	0.00168	CcSEcCtD
Tapentadol—Headache—Erlotinib—pancreatic cancer	0.000385	0.00168	CcSEcCtD
Tapentadol—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000384	0.00168	CcSEcCtD
Tapentadol—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000384	0.00168	CcSEcCtD
Tapentadol—Paraesthesia—Gemcitabine—pancreatic cancer	0.000383	0.00167	CcSEcCtD
Tapentadol—Chills—Docetaxel—pancreatic cancer	0.000382	0.00167	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000382	0.00167	CcSEcCtD
Tapentadol—Asthenia—Sunitinib—pancreatic cancer	0.000381	0.00166	CcSEcCtD
Tapentadol—Decreased appetite—Irinotecan—pancreatic cancer	0.000381	0.00166	CcSEcCtD
Tapentadol—Dyspnoea—Gemcitabine—pancreatic cancer	0.00038	0.00166	CcSEcCtD
Tapentadol—Insomnia—Fluorouracil—pancreatic cancer	0.000379	0.00166	CcSEcCtD
Tapentadol—Somnolence—Gemcitabine—pancreatic cancer	0.000379	0.00166	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000378	0.00165	CcSEcCtD
Tapentadol—Fatigue—Irinotecan—pancreatic cancer	0.000378	0.00165	CcSEcCtD
Tapentadol—Paraesthesia—Fluorouracil—pancreatic cancer	0.000377	0.00164	CcSEcCtD
Tapentadol—Pruritus—Sunitinib—pancreatic cancer	0.000376	0.00164	CcSEcCtD
Tapentadol—Breast disorder—Epirubicin—pancreatic cancer	0.000375	0.00164	CcSEcCtD
Tapentadol—Constipation—Irinotecan—pancreatic cancer	0.000375	0.00163	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000374	0.00163	CcSEcCtD
Tapentadol—Dyspnoea—Fluorouracil—pancreatic cancer	0.000374	0.00163	CcSEcCtD
Tapentadol—Mental disorder—Docetaxel—pancreatic cancer	0.000373	0.00163	CcSEcCtD
Tapentadol—Somnolence—Fluorouracil—pancreatic cancer	0.000373	0.00163	CcSEcCtD
Tapentadol—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000372	0.00162	CcSEcCtD
Tapentadol—Malnutrition—Docetaxel—pancreatic cancer	0.000371	0.00162	CcSEcCtD
Tapentadol—Decreased appetite—Gemcitabine—pancreatic cancer	0.000371	0.00162	CcSEcCtD
Tapentadol—Dyspepsia—Fluorouracil—pancreatic cancer	0.000369	0.00161	CcSEcCtD
Tapentadol—Nausea—Tamoxifen—pancreatic cancer	0.000369	0.00161	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000368	0.00161	CcSEcCtD
Tapentadol—Fatigue—Gemcitabine—pancreatic cancer	0.000368	0.00161	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000366	0.0016	CcSEcCtD
Tapentadol—Constipation—Gemcitabine—pancreatic cancer	0.000365	0.00159	CcSEcCtD
Tapentadol—Nausea—Erlotinib—pancreatic cancer	0.000365	0.00159	CcSEcCtD
Tapentadol—Decreased appetite—Fluorouracil—pancreatic cancer	0.000365	0.00159	CcSEcCtD
Tapentadol—Diarrhoea—Sunitinib—pancreatic cancer	0.000364	0.00159	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000362	0.00158	CcSEcCtD
Tapentadol—Ataxia—Doxorubicin—pancreatic cancer	0.000362	0.00158	CcSEcCtD
Tapentadol—Feeling abnormal—Irinotecan—pancreatic cancer	0.000361	0.00157	CcSEcCtD
Tapentadol—Dizziness—Sunitinib—pancreatic cancer	0.000352	0.00153	CcSEcCtD
Tapentadol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000352	0.00153	CcSEcCtD
Tapentadol—Breast disorder—Doxorubicin—pancreatic cancer	0.000347	0.00152	CcSEcCtD
Tapentadol—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000346	0.00151	CcSEcCtD
Tapentadol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000346	0.00151	CcSEcCtD
Tapentadol—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000344	0.0015	CcSEcCtD
Tapentadol—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000339	0.00148	CcSEcCtD
Tapentadol—Vomiting—Sunitinib—pancreatic cancer	0.000338	0.00148	CcSEcCtD
Tapentadol—Rash—Sunitinib—pancreatic cancer	0.000335	0.00146	CcSEcCtD
Tapentadol—Dermatitis—Sunitinib—pancreatic cancer	0.000335	0.00146	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000334	0.00146	CcSEcCtD
Tapentadol—Urticaria—Fluorouracil—pancreatic cancer	0.000333	0.00145	CcSEcCtD
Tapentadol—Headache—Sunitinib—pancreatic cancer	0.000333	0.00145	CcSEcCtD
Tapentadol—Syncope—Docetaxel—pancreatic cancer	0.000333	0.00145	CcSEcCtD
Tapentadol—Pollakiuria—Epirubicin—pancreatic cancer	0.000332	0.00145	CcSEcCtD
Tapentadol—Palpitations—Docetaxel—pancreatic cancer	0.000328	0.00143	CcSEcCtD
Tapentadol—Loss of consciousness—Docetaxel—pancreatic cancer	0.000326	0.00142	CcSEcCtD
Tapentadol—Weight decreased—Epirubicin—pancreatic cancer	0.000325	0.00142	CcSEcCtD
Tapentadol—Cough—Docetaxel—pancreatic cancer	0.000324	0.00141	CcSEcCtD
Tapentadol—Hypersensitivity—Irinotecan—pancreatic cancer	0.000323	0.00141	CcSEcCtD
Tapentadol—Convulsion—Docetaxel—pancreatic cancer	0.000321	0.0014	CcSEcCtD
Tapentadol—Infestation NOS—Epirubicin—pancreatic cancer	0.00032	0.0014	CcSEcCtD
Tapentadol—Infestation—Epirubicin—pancreatic cancer	0.00032	0.0014	CcSEcCtD
Tapentadol—Arthralgia—Docetaxel—pancreatic cancer	0.000316	0.00138	CcSEcCtD
Tapentadol—Nausea—Sunitinib—pancreatic cancer	0.000316	0.00138	CcSEcCtD
Tapentadol—Asthenia—Irinotecan—pancreatic cancer	0.000314	0.00137	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000314	0.00137	CcSEcCtD
Tapentadol—Urinary tract infection—Epirubicin—pancreatic cancer	0.000311	0.00136	CcSEcCtD
Tapentadol—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000309	0.00135	CcSEcCtD
Tapentadol—Dry mouth—Docetaxel—pancreatic cancer	0.000309	0.00135	CcSEcCtD
Tapentadol—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000309	0.00135	CcSEcCtD
Tapentadol—Pollakiuria—Doxorubicin—pancreatic cancer	0.000307	0.00134	CcSEcCtD
Tapentadol—Asthenia—Gemcitabine—pancreatic cancer	0.000306	0.00134	CcSEcCtD
Tapentadol—Confusional state—Docetaxel—pancreatic cancer	0.000305	0.00133	CcSEcCtD
Tapentadol—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000303	0.00132	CcSEcCtD
Tapentadol—Oedema—Docetaxel—pancreatic cancer	0.000303	0.00132	CcSEcCtD
Tapentadol—Pruritus—Gemcitabine—pancreatic cancer	0.000302	0.00132	CcSEcCtD
Tapentadol—Infection—Docetaxel—pancreatic cancer	0.000301	0.00131	CcSEcCtD
Tapentadol—Weight decreased—Doxorubicin—pancreatic cancer	0.000301	0.00131	CcSEcCtD
Tapentadol—Diarrhoea—Irinotecan—pancreatic cancer	0.0003	0.00131	CcSEcCtD
Tapentadol—Shock—Docetaxel—pancreatic cancer	0.000298	0.0013	CcSEcCtD
Tapentadol—Nervous system disorder—Docetaxel—pancreatic cancer	0.000297	0.0013	CcSEcCtD
Tapentadol—Pruritus—Fluorouracil—pancreatic cancer	0.000297	0.0013	CcSEcCtD
Tapentadol—Infestation—Doxorubicin—pancreatic cancer	0.000296	0.00129	CcSEcCtD
Tapentadol—Infestation NOS—Doxorubicin—pancreatic cancer	0.000296	0.00129	CcSEcCtD
Tapentadol—Tachycardia—Docetaxel—pancreatic cancer	0.000295	0.00129	CcSEcCtD
Tapentadol—Skin disorder—Docetaxel—pancreatic cancer	0.000294	0.00128	CcSEcCtD
Tapentadol—Bradycardia—Epirubicin—pancreatic cancer	0.000293	0.00128	CcSEcCtD
Tapentadol—Diarrhoea—Gemcitabine—pancreatic cancer	0.000292	0.00127	CcSEcCtD
Tapentadol—Dizziness—Irinotecan—pancreatic cancer	0.00029	0.00126	CcSEcCtD
Tapentadol—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000288	0.00126	CcSEcCtD
Tapentadol—Diarrhoea—Fluorouracil—pancreatic cancer	0.000287	0.00125	CcSEcCtD
Tapentadol—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000286	0.00125	CcSEcCtD
Tapentadol—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000284	0.00124	CcSEcCtD
Tapentadol—Hypotension—Docetaxel—pancreatic cancer	0.000283	0.00123	CcSEcCtD
Tapentadol—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000282	0.00123	CcSEcCtD
Tapentadol—Urethral disorder—Epirubicin—pancreatic cancer	0.000282	0.00123	CcSEcCtD
Tapentadol—Vomiting—Irinotecan—pancreatic cancer	0.000278	0.00122	CcSEcCtD
Tapentadol—Dizziness—Fluorouracil—pancreatic cancer	0.000277	0.00121	CcSEcCtD
Tapentadol—Visual impairment—Epirubicin—pancreatic cancer	0.000277	0.00121	CcSEcCtD
Tapentadol—Rash—Irinotecan—pancreatic cancer	0.000276	0.00121	CcSEcCtD
Tapentadol—Dermatitis—Irinotecan—pancreatic cancer	0.000276	0.0012	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000276	0.0012	CcSEcCtD
Tapentadol—Headache—Irinotecan—pancreatic cancer	0.000274	0.0012	CcSEcCtD
Tapentadol—Insomnia—Docetaxel—pancreatic cancer	0.000274	0.00119	CcSEcCtD
Tapentadol—Paraesthesia—Docetaxel—pancreatic cancer	0.000272	0.00119	CcSEcCtD
Tapentadol—Vomiting—Gemcitabine—pancreatic cancer	0.000271	0.00118	CcSEcCtD
Tapentadol—Bradycardia—Doxorubicin—pancreatic cancer	0.000271	0.00118	CcSEcCtD
Tapentadol—Dyspnoea—Docetaxel—pancreatic cancer	0.00027	0.00118	CcSEcCtD
Tapentadol—Somnolence—Docetaxel—pancreatic cancer	0.000269	0.00117	CcSEcCtD
Tapentadol—Rash—Gemcitabine—pancreatic cancer	0.000269	0.00117	CcSEcCtD
Tapentadol—Dermatitis—Gemcitabine—pancreatic cancer	0.000269	0.00117	CcSEcCtD
Tapentadol—Eye disorder—Epirubicin—pancreatic cancer	0.000269	0.00117	CcSEcCtD
Tapentadol—Headache—Gemcitabine—pancreatic cancer	0.000267	0.00117	CcSEcCtD
Tapentadol—Cardiac disorder—Epirubicin—pancreatic cancer	0.000267	0.00116	CcSEcCtD
Tapentadol—Vomiting—Fluorouracil—pancreatic cancer	0.000267	0.00116	CcSEcCtD
Tapentadol—Dyspepsia—Docetaxel—pancreatic cancer	0.000267	0.00116	CcSEcCtD
Tapentadol—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000265	0.00115	CcSEcCtD
Tapentadol—Rash—Fluorouracil—pancreatic cancer	0.000264	0.00115	CcSEcCtD
Tapentadol—Dermatitis—Fluorouracil—pancreatic cancer	0.000264	0.00115	CcSEcCtD
Tapentadol—Decreased appetite—Docetaxel—pancreatic cancer	0.000263	0.00115	CcSEcCtD
Tapentadol—Headache—Fluorouracil—pancreatic cancer	0.000263	0.00115	CcSEcCtD
Tapentadol—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000263	0.00115	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000261	0.00114	CcSEcCtD
Tapentadol—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000261	0.00114	CcSEcCtD
Tapentadol—Fatigue—Docetaxel—pancreatic cancer	0.000261	0.00114	CcSEcCtD
Tapentadol—Angiopathy—Epirubicin—pancreatic cancer	0.000261	0.00114	CcSEcCtD
Tapentadol—Urethral disorder—Doxorubicin—pancreatic cancer	0.000261	0.00114	CcSEcCtD
Tapentadol—Nausea—Irinotecan—pancreatic cancer	0.00026	0.00114	CcSEcCtD
Tapentadol—Immune system disorder—Epirubicin—pancreatic cancer	0.00026	0.00113	CcSEcCtD
Tapentadol—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000259	0.00113	CcSEcCtD
Tapentadol—Constipation—Docetaxel—pancreatic cancer	0.000259	0.00113	CcSEcCtD
Tapentadol—Chills—Epirubicin—pancreatic cancer	0.000258	0.00113	CcSEcCtD
Tapentadol—Visual impairment—Doxorubicin—pancreatic cancer	0.000256	0.00112	CcSEcCtD
Tapentadol—Nausea—Gemcitabine—pancreatic cancer	0.000253	0.00111	CcSEcCtD
Tapentadol—Mental disorder—Epirubicin—pancreatic cancer	0.000252	0.0011	CcSEcCtD
Tapentadol—Malnutrition—Epirubicin—pancreatic cancer	0.00025	0.00109	CcSEcCtD
Tapentadol—Feeling abnormal—Docetaxel—pancreatic cancer	0.00025	0.00109	CcSEcCtD
Tapentadol—Nausea—Fluorouracil—pancreatic cancer	0.000249	0.00109	CcSEcCtD
Tapentadol—Eye disorder—Doxorubicin—pancreatic cancer	0.000249	0.00108	CcSEcCtD
Tapentadol—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000247	0.00108	CcSEcCtD
Tapentadol—Tension—Epirubicin—pancreatic cancer	0.000246	0.00107	CcSEcCtD
Tapentadol—Nervousness—Epirubicin—pancreatic cancer	0.000243	0.00106	CcSEcCtD
Tapentadol—Angiopathy—Doxorubicin—pancreatic cancer	0.000241	0.00105	CcSEcCtD
Tapentadol—Immune system disorder—Doxorubicin—pancreatic cancer	0.00024	0.00105	CcSEcCtD
Tapentadol—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.00024	0.00105	CcSEcCtD
Tapentadol—Chills—Doxorubicin—pancreatic cancer	0.000239	0.00104	CcSEcCtD
Tapentadol—Vision blurred—Epirubicin—pancreatic cancer	0.000236	0.00103	CcSEcCtD
Tapentadol—Mental disorder—Doxorubicin—pancreatic cancer	0.000233	0.00102	CcSEcCtD
Tapentadol—Malnutrition—Doxorubicin—pancreatic cancer	0.000232	0.00101	CcSEcCtD
Tapentadol—Agitation—Epirubicin—pancreatic cancer	0.00023	0.001	CcSEcCtD
Tapentadol—Tension—Doxorubicin—pancreatic cancer	0.000227	0.000991	CcSEcCtD
Tapentadol—Nervousness—Doxorubicin—pancreatic cancer	0.000225	0.000981	CcSEcCtD
Tapentadol—Vertigo—Epirubicin—pancreatic cancer	0.000225	0.000981	CcSEcCtD
Tapentadol—Syncope—Epirubicin—pancreatic cancer	0.000224	0.000979	CcSEcCtD
Tapentadol—Hypersensitivity—Docetaxel—pancreatic cancer	0.000223	0.000973	CcSEcCtD
Tapentadol—Palpitations—Epirubicin—pancreatic cancer	0.000221	0.000965	CcSEcCtD
Tapentadol—Loss of consciousness—Epirubicin—pancreatic cancer	0.00022	0.00096	CcSEcCtD
Tapentadol—Cough—Epirubicin—pancreatic cancer	0.000218	0.000953	CcSEcCtD
Tapentadol—Vision blurred—Doxorubicin—pancreatic cancer	0.000218	0.000952	CcSEcCtD
Tapentadol—Asthenia—Docetaxel—pancreatic cancer	0.000217	0.000948	CcSEcCtD
Tapentadol—Convulsion—Epirubicin—pancreatic cancer	0.000217	0.000946	CcSEcCtD
Tapentadol—Pruritus—Docetaxel—pancreatic cancer	0.000214	0.000935	CcSEcCtD
Tapentadol—Arthralgia—Epirubicin—pancreatic cancer	0.000213	0.00093	CcSEcCtD
Tapentadol—Agitation—Doxorubicin—pancreatic cancer	0.000213	0.000928	CcSEcCtD
Tapentadol—Anxiety—Epirubicin—pancreatic cancer	0.000212	0.000926	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000212	0.000923	CcSEcCtD
Tapentadol—Dry mouth—Epirubicin—pancreatic cancer	0.000208	0.000909	CcSEcCtD
Tapentadol—Vertigo—Doxorubicin—pancreatic cancer	0.000208	0.000908	CcSEcCtD
Tapentadol—Syncope—Doxorubicin—pancreatic cancer	0.000208	0.000906	CcSEcCtD
Tapentadol—Diarrhoea—Docetaxel—pancreatic cancer	0.000207	0.000904	CcSEcCtD
Tapentadol—Confusional state—Epirubicin—pancreatic cancer	0.000206	0.000899	CcSEcCtD
Tapentadol—Palpitations—Doxorubicin—pancreatic cancer	0.000205	0.000893	CcSEcCtD
Tapentadol—Oedema—Epirubicin—pancreatic cancer	0.000204	0.000891	CcSEcCtD
Tapentadol—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000204	0.000891	CcSEcCtD
Tapentadol—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000203	0.000888	CcSEcCtD
Tapentadol—Infection—Epirubicin—pancreatic cancer	0.000203	0.000885	CcSEcCtD
Tapentadol—Cough—Doxorubicin—pancreatic cancer	0.000202	0.000882	CcSEcCtD
Tapentadol—Shock—Epirubicin—pancreatic cancer	0.000201	0.000877	CcSEcCtD
Tapentadol—Convulsion—Doxorubicin—pancreatic cancer	0.000201	0.000875	CcSEcCtD
Tapentadol—Nervous system disorder—Epirubicin—pancreatic cancer	0.0002	0.000874	CcSEcCtD
Tapentadol—Dizziness—Docetaxel—pancreatic cancer	0.0002	0.000874	CcSEcCtD
Tapentadol—Tachycardia—Epirubicin—pancreatic cancer	0.000199	0.00087	CcSEcCtD
Tapentadol—Skin disorder—Epirubicin—pancreatic cancer	0.000198	0.000866	CcSEcCtD
Tapentadol—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000197	0.000861	CcSEcCtD
Tapentadol—Arthralgia—Doxorubicin—pancreatic cancer	0.000197	0.00086	CcSEcCtD
Tapentadol—Anxiety—Doxorubicin—pancreatic cancer	0.000196	0.000857	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000196	0.000854	CcSEcCtD
Tapentadol—Dry mouth—Doxorubicin—pancreatic cancer	0.000193	0.000841	CcSEcCtD
Tapentadol—Vomiting—Docetaxel—pancreatic cancer	0.000193	0.00084	CcSEcCtD
Tapentadol—Rash—Docetaxel—pancreatic cancer	0.000191	0.000833	CcSEcCtD
Tapentadol—Hypotension—Epirubicin—pancreatic cancer	0.000191	0.000833	CcSEcCtD
Tapentadol—Dermatitis—Docetaxel—pancreatic cancer	0.000191	0.000832	CcSEcCtD
Tapentadol—Confusional state—Doxorubicin—pancreatic cancer	0.000191	0.000831	CcSEcCtD
Tapentadol—Headache—Docetaxel—pancreatic cancer	0.00019	0.000828	CcSEcCtD
Tapentadol—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000189	0.000825	CcSEcCtD
Tapentadol—Oedema—Doxorubicin—pancreatic cancer	0.000189	0.000825	CcSEcCtD
Tapentadol—Infection—Doxorubicin—pancreatic cancer	0.000188	0.000819	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000186	0.000812	CcSEcCtD
Tapentadol—Shock—Doxorubicin—pancreatic cancer	0.000186	0.000811	CcSEcCtD
Tapentadol—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000185	0.000809	CcSEcCtD
Tapentadol—Insomnia—Epirubicin—pancreatic cancer	0.000185	0.000806	CcSEcCtD
Tapentadol—Tachycardia—Doxorubicin—pancreatic cancer	0.000184	0.000805	CcSEcCtD
Tapentadol—Skin disorder—Doxorubicin—pancreatic cancer	0.000184	0.000801	CcSEcCtD
Tapentadol—Paraesthesia—Epirubicin—pancreatic cancer	0.000183	0.0008	CcSEcCtD
Tapentadol—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000183	0.000797	CcSEcCtD
Tapentadol—Dyspnoea—Epirubicin—pancreatic cancer	0.000182	0.000794	CcSEcCtD
Tapentadol—Somnolence—Epirubicin—pancreatic cancer	0.000182	0.000792	CcSEcCtD
Tapentadol—Nausea—Docetaxel—pancreatic cancer	0.00018	0.000785	CcSEcCtD
Tapentadol—Dyspepsia—Epirubicin—pancreatic cancer	0.00018	0.000784	CcSEcCtD
Tapentadol—Decreased appetite—Epirubicin—pancreatic cancer	0.000178	0.000775	CcSEcCtD
Tapentadol—Hypotension—Doxorubicin—pancreatic cancer	0.000177	0.00077	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000176	0.000769	CcSEcCtD
Tapentadol—Fatigue—Epirubicin—pancreatic cancer	0.000176	0.000768	CcSEcCtD
Tapentadol—Constipation—Epirubicin—pancreatic cancer	0.000175	0.000762	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000172	0.000751	CcSEcCtD
Tapentadol—Insomnia—Doxorubicin—pancreatic cancer	0.000171	0.000746	CcSEcCtD
Tapentadol—Paraesthesia—Doxorubicin—pancreatic cancer	0.00017	0.00074	CcSEcCtD
Tapentadol—Dyspnoea—Doxorubicin—pancreatic cancer	0.000168	0.000735	CcSEcCtD
Tapentadol—Feeling abnormal—Epirubicin—pancreatic cancer	0.000168	0.000734	CcSEcCtD
Tapentadol—Somnolence—Doxorubicin—pancreatic cancer	0.000168	0.000733	CcSEcCtD
Tapentadol—Dyspepsia—Doxorubicin—pancreatic cancer	0.000166	0.000726	CcSEcCtD
Tapentadol—Decreased appetite—Doxorubicin—pancreatic cancer	0.000164	0.000717	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000163	0.000712	CcSEcCtD
Tapentadol—Fatigue—Doxorubicin—pancreatic cancer	0.000163	0.000711	CcSEcCtD
Tapentadol—Urticaria—Epirubicin—pancreatic cancer	0.000162	0.000708	CcSEcCtD
Tapentadol—Constipation—Doxorubicin—pancreatic cancer	0.000162	0.000705	CcSEcCtD
Tapentadol—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000156	0.000679	CcSEcCtD
Tapentadol—Hypersensitivity—Epirubicin—pancreatic cancer	0.00015	0.000657	CcSEcCtD
Tapentadol—Urticaria—Doxorubicin—pancreatic cancer	0.00015	0.000655	CcSEcCtD
Tapentadol—Asthenia—Epirubicin—pancreatic cancer	0.000147	0.000639	CcSEcCtD
Tapentadol—Pruritus—Epirubicin—pancreatic cancer	0.000144	0.00063	CcSEcCtD
Tapentadol—Diarrhoea—Epirubicin—pancreatic cancer	0.00014	0.00061	CcSEcCtD
Tapentadol—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000139	0.000607	CcSEcCtD
Tapentadol—Asthenia—Doxorubicin—pancreatic cancer	0.000136	0.000592	CcSEcCtD
Tapentadol—Dizziness—Epirubicin—pancreatic cancer	0.000135	0.000589	CcSEcCtD
Tapentadol—Pruritus—Doxorubicin—pancreatic cancer	0.000134	0.000583	CcSEcCtD
Tapentadol—Vomiting—Epirubicin—pancreatic cancer	0.00013	0.000567	CcSEcCtD
Tapentadol—Diarrhoea—Doxorubicin—pancreatic cancer	0.000129	0.000564	CcSEcCtD
Tapentadol—Rash—Epirubicin—pancreatic cancer	0.000129	0.000562	CcSEcCtD
Tapentadol—Dermatitis—Epirubicin—pancreatic cancer	0.000129	0.000561	CcSEcCtD
Tapentadol—Headache—Epirubicin—pancreatic cancer	0.000128	0.000558	CcSEcCtD
Tapentadol—Dizziness—Doxorubicin—pancreatic cancer	0.000125	0.000545	CcSEcCtD
Tapentadol—Nausea—Epirubicin—pancreatic cancer	0.000121	0.000529	CcSEcCtD
Tapentadol—Vomiting—Doxorubicin—pancreatic cancer	0.00012	0.000524	CcSEcCtD
Tapentadol—Rash—Doxorubicin—pancreatic cancer	0.000119	0.00052	CcSEcCtD
Tapentadol—Dermatitis—Doxorubicin—pancreatic cancer	0.000119	0.000519	CcSEcCtD
Tapentadol—Headache—Doxorubicin—pancreatic cancer	0.000118	0.000517	CcSEcCtD
Tapentadol—Nausea—Doxorubicin—pancreatic cancer	0.000112	0.00049	CcSEcCtD
Tapentadol—UGT1A9—Metabolism—CD44—pancreatic cancer	3.95e-05	0.000312	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—STK11—pancreatic cancer	3.93e-05	0.00031	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.87e-05	0.000305	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PRSS1—pancreatic cancer	3.87e-05	0.000305	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PRSS1—pancreatic cancer	3.84e-05	0.000303	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.83e-05	0.000303	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PTHLH—pancreatic cancer	3.8e-05	0.0003	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PTCH1—pancreatic cancer	3.8e-05	0.0003	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CNR1—pancreatic cancer	3.8e-05	0.000299	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—GCG—pancreatic cancer	3.79e-05	0.000299	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—TYMS—pancreatic cancer	3.77e-05	0.000298	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—PIK3CD—pancreatic cancer	3.69e-05	0.000291	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PIK3CG—pancreatic cancer	3.68e-05	0.000291	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—GCG—pancreatic cancer	3.67e-05	0.000289	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ARG2—pancreatic cancer	3.65e-05	0.000288	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.57e-05	0.000281	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—STK11—pancreatic cancer	3.56e-05	0.000281	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.54e-05	0.00028	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AGTR1—pancreatic cancer	3.5e-05	0.000276	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SST—pancreatic cancer	3.48e-05	0.000274	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—STK11—pancreatic cancer	3.45e-05	0.000272	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SMAD4—pancreatic cancer	3.44e-05	0.000272	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.43e-05	0.00027	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CXCL8—pancreatic cancer	3.41e-05	0.000269	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—JAG1—pancreatic cancer	3.4e-05	0.000268	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOTCH3—pancreatic cancer	3.39e-05	0.000267	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HES1—pancreatic cancer	3.36e-05	0.000265	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ARG2—pancreatic cancer	3.35e-05	0.000265	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.34e-05	0.000264	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ARG2—pancreatic cancer	3.33e-05	0.000262	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PIK3CD—pancreatic cancer	3.24e-05	0.000255	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—PIK3CB—pancreatic cancer	3.22e-05	0.000254	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CNR1—pancreatic cancer	3.21e-05	0.000253	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TYMP—pancreatic cancer	3.19e-05	0.000251	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	3.11e-05	0.000246	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.11e-05	0.000245	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—GCG—pancreatic cancer	3.1e-05	0.000244	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CXCL8—pancreatic cancer	3.09e-05	0.000244	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—APOE—pancreatic cancer	3.07e-05	0.000242	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—TYMS—pancreatic cancer	3.06e-05	0.000242	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SMAD4—pancreatic cancer	3.02e-05	0.000238	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.01e-05	0.000238	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.99e-05	0.000236	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AGTR1—pancreatic cancer	2.96e-05	0.000233	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HES1—pancreatic cancer	2.95e-05	0.000233	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TERT—pancreatic cancer	2.95e-05	0.000232	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TYMP—pancreatic cancer	2.93e-05	0.000231	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—STK11—pancreatic cancer	2.91e-05	0.00023	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TYMP—pancreatic cancer	2.91e-05	0.000229	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.82e-05	0.000223	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HIF1A—pancreatic cancer	2.82e-05	0.000222	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TSC2—pancreatic cancer	2.81e-05	0.000222	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PIK3CG—pancreatic cancer	2.77e-05	0.000218	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—APOE—pancreatic cancer	2.75e-05	0.000217	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.74e-05	0.000216	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CXCL8—pancreatic cancer	2.71e-05	0.000214	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—KDR—pancreatic cancer	2.69e-05	0.000213	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PPARG—pancreatic cancer	2.67e-05	0.000211	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.63e-05	0.000207	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.63e-05	0.000207	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TERT—pancreatic cancer	2.58e-05	0.000204	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GLP1R—pancreatic cancer	2.57e-05	0.000203	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NFKBIA—pancreatic cancer	2.56e-05	0.000202	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SMAD4—pancreatic cancer	2.55e-05	0.000201	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NOTCH1—pancreatic cancer	2.54e-05	0.0002	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—DPYD—pancreatic cancer	2.53e-05	0.000199	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.52e-05	0.000199	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—APOE—pancreatic cancer	2.49e-05	0.000197	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HES1—pancreatic cancer	2.49e-05	0.000197	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PIK3CG—pancreatic cancer	2.48e-05	0.000196	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—NRAS—pancreatic cancer	2.48e-05	0.000196	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HIF1A—pancreatic cancer	2.47e-05	0.000195	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TSC2—pancreatic cancer	2.46e-05	0.000194	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—EGF—pancreatic cancer	2.45e-05	0.000194	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PIK3CD—pancreatic cancer	2.43e-05	0.000192	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—APOE—pancreatic cancer	2.41e-05	0.00019	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	2.4e-05	0.000189	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.4e-05	0.000189	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.39e-05	0.000188	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.37e-05	0.000187	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GLP1R—pancreatic cancer	2.36e-05	0.000186	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—KDR—pancreatic cancer	2.36e-05	0.000186	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.36e-05	0.000186	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GLP1R—pancreatic cancer	2.34e-05	0.000185	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—DPYD—pancreatic cancer	2.32e-05	0.000183	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—DPYD—pancreatic cancer	2.3e-05	0.000182	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCL8—pancreatic cancer	2.29e-05	0.000181	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.29e-05	0.000181	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—EGFR—pancreatic cancer	2.26e-05	0.000178	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3CG—pancreatic cancer	2.25e-05	0.000177	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NFKBIA—pancreatic cancer	2.25e-05	0.000177	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NOTCH1—pancreatic cancer	2.23e-05	0.000176	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	2.21e-05	0.000174	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	2.19e-05	0.000173	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TERT—pancreatic cancer	2.18e-05	0.000172	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PIK3CD—pancreatic cancer	2.18e-05	0.000172	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PIK3CG—pancreatic cancer	2.18e-05	0.000172	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—NRAS—pancreatic cancer	2.18e-05	0.000172	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PPARG—pancreatic cancer	2.17e-05	0.000171	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.16e-05	0.000171	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.16e-05	0.00017	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—EGF—pancreatic cancer	2.15e-05	0.00017	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—KRAS—pancreatic cancer	2.14e-05	0.000168	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PIK3CB—pancreatic cancer	2.12e-05	0.000167	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTGS2—pancreatic cancer	2.1e-05	0.000166	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.09e-05	0.000165	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HIF1A—pancreatic cancer	2.09e-05	0.000165	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.09e-05	0.000165	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TSC2—pancreatic cancer	2.08e-05	0.000164	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—APOE—pancreatic cancer	2.04e-05	0.000161	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—KDR—pancreatic cancer	2e-05	0.000157	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—EGFR—pancreatic cancer	1.98e-05	0.000156	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3CD—pancreatic cancer	1.98e-05	0.000156	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.96e-05	0.000155	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PIK3CD—pancreatic cancer	1.91e-05	0.000151	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.9e-05	0.00015	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PIK3CB—pancreatic cancer	1.9e-05	0.00015	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NFKBIA—pancreatic cancer	1.9e-05	0.00015	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.89e-05	0.000149	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOTCH1—pancreatic cancer	1.88e-05	0.000148	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—KRAS—pancreatic cancer	1.87e-05	0.000148	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—CD44—pancreatic cancer	1.86e-05	0.000147	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3CG—pancreatic cancer	1.84e-05	0.000145	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—NRAS—pancreatic cancer	1.84e-05	0.000145	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTEN—pancreatic cancer	1.83e-05	0.000145	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCL8—pancreatic cancer	1.83e-05	0.000144	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.82e-05	0.000143	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EGF—pancreatic cancer	1.82e-05	0.000143	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—HRAS—pancreatic cancer	1.82e-05	0.000143	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.8e-05	0.000142	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—GCG—pancreatic cancer	1.78e-05	0.00014	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—AKT1—pancreatic cancer	1.77e-05	0.000139	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CASP3—pancreatic cancer	1.75e-05	0.000138	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3CB—pancreatic cancer	1.72e-05	0.000136	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.72e-05	0.000136	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—CD44—pancreatic cancer	1.71e-05	0.000135	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTGS2—pancreatic cancer	1.71e-05	0.000135	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCND1—pancreatic cancer	1.7e-05	0.000134	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—CD44—pancreatic cancer	1.69e-05	0.000134	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CTNNB1—pancreatic cancer	1.69e-05	0.000133	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—EGFR—pancreatic cancer	1.68e-05	0.000132	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—STK11—pancreatic cancer	1.67e-05	0.000132	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	1.67e-05	0.000132	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.66e-05	0.000131	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MMP9—pancreatic cancer	1.65e-05	0.00013	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.64e-05	0.00013	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PTEN—pancreatic cancer	1.64e-05	0.00013	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—GCG—pancreatic cancer	1.64e-05	0.000129	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—GCG—pancreatic cancer	1.62e-05	0.000128	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3CD—pancreatic cancer	1.62e-05	0.000128	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—AKT1—pancreatic cancer	1.6e-05	0.000126	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	1.6e-05	0.000126	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.6e-05	0.000126	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	1.59e-05	0.000126	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—KRAS—pancreatic cancer	1.58e-05	0.000125	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.57e-05	0.000124	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	1.55e-05	0.000122	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—STK11—pancreatic cancer	1.54e-05	0.000121	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	1.53e-05	0.000121	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—STK11—pancreatic cancer	1.53e-05	0.00012	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SRC—pancreatic cancer	1.52e-05	0.00012	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	1.49e-05	0.000118	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTEN—pancreatic cancer	1.49e-05	0.000117	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—VEGFA—pancreatic cancer	1.48e-05	0.000117	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	1.48e-05	0.000117	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—STAT3—pancreatic cancer	1.47e-05	0.000116	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NRAS—pancreatic cancer	1.47e-05	0.000116	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.45e-05	0.000115	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	1.45e-05	0.000114	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	1.44e-05	0.000114	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—TYMS—pancreatic cancer	1.44e-05	0.000114	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.43e-05	0.000113	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3CB—pancreatic cancer	1.41e-05	0.000111	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	1.41e-05	0.000111	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MYC—pancreatic cancer	1.37e-05	0.000108	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TGFB1—pancreatic cancer	1.36e-05	0.000107	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCL8—pancreatic cancer	1.35e-05	0.000107	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—HRAS—pancreatic cancer	1.35e-05	0.000106	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SRC—pancreatic cancer	1.34e-05	0.000105	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—EGFR—pancreatic cancer	1.34e-05	0.000105	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.32e-05	0.000105	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—TYMS—pancreatic cancer	1.31e-05	0.000104	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—AKT1—pancreatic cancer	1.31e-05	0.000103	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	1.3e-05	0.000103	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CASP3—pancreatic cancer	1.3e-05	0.000102	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PIK3CA—pancreatic cancer	1.29e-05	0.000102	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	1.29e-05	0.000102	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	1.29e-05	0.000101	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—KRAS—pancreatic cancer	1.26e-05	9.95e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCND1—pancreatic cancer	1.26e-05	9.95e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CTNNB1—pancreatic cancer	1.25e-05	9.86e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MMP9—pancreatic cancer	1.22e-05	9.66e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PTEN—pancreatic cancer	1.22e-05	9.61e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MYC—pancreatic cancer	1.2e-05	9.45e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	1.19e-05	9.42e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—AKT1—pancreatic cancer	1.19e-05	9.37e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—APOE—pancreatic cancer	1.17e-05	9.24e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	1.17e-05	9.24e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PIK3CA—pancreatic cancer	1.16e-05	9.14e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SRC—pancreatic cancer	1.13e-05	8.91e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TP53—pancreatic cancer	1.12e-05	8.85e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.11e-05	8.75e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	1.11e-05	8.73e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—VEGFA—pancreatic cancer	1.1e-05	8.68e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—STAT3—pancreatic cancer	1.09e-05	8.59e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NRAS—pancreatic cancer	1.09e-05	8.57e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—APOE—pancreatic cancer	1.08e-05	8.5e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HRAS—pancreatic cancer	1.07e-05	8.46e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—APOE—pancreatic cancer	1.07e-05	8.43e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	1.06e-05	8.34e-05	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—AKT1—pancreatic cancer	1.06e-05	8.33e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PIK3CA—pancreatic cancer	1.05e-05	8.29e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPARG—pancreatic cancer	1.02e-05	8.05e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	1.02e-05	8.02e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MYC—pancreatic cancer	1.01e-05	7.98e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.01e-05	7.98e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TGFB1—pancreatic cancer	1.01e-05	7.96e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EGFR—pancreatic cancer	9.9e-06	7.81e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TP53—pancreatic cancer	9.83e-06	7.76e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	9.72e-06	7.67e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	9.64e-06	7.6e-05	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—AKT1—pancreatic cancer	9.47e-06	7.47e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	9.4e-06	7.42e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPARG—pancreatic cancer	9.38e-06	7.4e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	9.35e-06	7.38e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPARG—pancreatic cancer	9.3e-06	7.34e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	9.29e-06	7.33e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	8.59e-06	6.78e-05	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—AKT1—pancreatic cancer	8.58e-06	6.77e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	8.55e-06	6.74e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	8.47e-06	6.68e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TP53—pancreatic cancer	8.31e-06	6.56e-05	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	8.3e-06	6.55e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	8.1e-06	6.39e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTGS2—pancreatic cancer	8.03e-06	6.33e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	7.95e-06	6.27e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	7.45e-06	5.88e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	7.39e-06	5.83e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTGS2—pancreatic cancer	7.38e-06	5.82e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTGS2—pancreatic cancer	7.32e-06	5.77e-05	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	7.02e-06	5.54e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTEN—pancreatic cancer	7e-06	5.52e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTEN—pancreatic cancer	6.44e-06	5.08e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTEN—pancreatic cancer	6.38e-06	5.03e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	4.94e-06	3.9e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	4.54e-06	3.58e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	4.5e-06	3.55e-05	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—AKT1—pancreatic cancer	4.03e-06	3.18e-05	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—AKT1—pancreatic cancer	3.71e-06	2.93e-05	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—AKT1—pancreatic cancer	3.68e-06	2.9e-05	CbGpPWpGaD
